NASS interacts with the Food & Drug Administration (FDA) on a regular basis to represent the interests of members and their patients related to devices and medications.
The NASS Health Policy and Research Councils monitor spine care-related activities at the FDA and provide input when appropriate. NASS representatives frequently attend the FDA’s Orthopedic and Rehabilitation Device Panel meetings to provide expert input on classification and re-classification of spine devices.
NASS also provides written comments on numerous FDA-related issues. Recent comment letters are available on the Scientific and Policy Comments page.